Company profile
Promethera Biosciences company profile
Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):
Business identity
- Website
- https://www.promethera.com/
- Contact email
- [email protected]
- Phone number
- 32 1 039 43 00
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $1M-$10M
- Founded
- 2009-01-01, Year
Headquarters
- Headquarters
- Mont-Saint-Guibert, Wallonia, Belgium
- Postal code
- B-1435
- Country code
- BE
- Continent
- Europe